Combining Opdivo and Yervoy is an effective treatment option for certain advanced cancers. You may find it helpful to explore specific details about this drug combination, including its uses, side ...

Opdivo and Yervoy are immunotherapy drugs that may be used together to treat certain types of advanced cancer. They can boost treatment efficacy and improve life expectancy. These drugs have several ...

The U.S. Food and Drug Administration (FDA) on Tuesday approved Bristol Myers Squibb & Co’s (NYSE:BMY) Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment of adult and pediatric ...

49% of patients treated with Opdivo plus Yervoy were alive at 6.5 years and 77% of these patients remained treatment-free Data to be featured in an oral presentation during the 2021 American Society ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) plus Yervoy (ipilimumab) continued to demonstrate long-term survival results in the Phase 3 ...

Yervoy (ipilimumab) is a brand-name medication administered by intravenous injection. It’s prescribed for certain types of cancer, including melanoma, kidney cancer, liver cancer, and lung cancer. The ...

None of the more than 100 evaluable patients with mismatch repair deficient colon cancer have experienced disease recurrence after treatment with presurgical Opdivo plus Yervoy, according to study ...

A phase 1 trial combines immunotherapy and an oncolytic virus for high-grade neuroendocrine tumors, aiming to enroll 36 patients by 2030. The trial evaluates Opdivo, Yervoy, and Seneca Valley ...

Yervoy (ipilimumab) is an immunotherapy drug used to treat various cancer types in adults, including melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, kidney cancer, liver cancer, ...

How Does Yervoy Work for Lung Cancer? Some cancer cells have what are called checkpoint proteins on their cell surface. The immune cells in our body also have proteins on their surface. When these ...